Using ZINC08918027 inhibitor to determine Aurora kinase-chromosomal passenger complex isoforms in mouse oocytes

Caroline Kratka1, David Drutovic2, Cecilia S Blengini1,3

  • 1Department of Genetics, Rutgers University, The State University of New Jersey, 145 Bevier Rd, Piscataway, NJ, 08854, USA.

BMC Research Notes
|March 8, 2022
PubMed
Abstract

Insights

A novel inhibitor revealed that Aurora kinase A (AURKA) and Aurora kinase C (AURKC) activities, dependent on INCENP, are crucial for proper spindle formation and meiotic progression in oocytes.

Area of Science:

  • Reproductive biology
  • Cell biology
  • Genetics

Background:

  • Aneuploidy in oocytes is a major cause of miscarriage, particularly in older women.
  • The Aurora kinase (AURK) family regulates chromosome segregation during meiosis.
  • Understanding the specific roles of AURK isoforms, like AURKA and AURKC, is vital for addressing aneuploidy.

Purpose of the Study:

  • To investigate the role of INCENP-binding Aurora kinases in mouse oocyte meiosis.
  • To test if the inhibitor ZINC08918027 (ZC) blocks chromosomal passenger complex (CPC) function for any AURK isoform.

Main Methods:

  • Treatment of mouse oocytes with ZC, an inhibitor of AURK-INCENP interaction.
  • Analysis of meiotic progression and spindle formation.
  • Western blotting and immunofluorescence to assess activated AURKA and AURKC levels.

Main Results:

  • ZC treatment disrupted meiotic progression and spindle assembly in oocytes.
  • Activated AURKA and AURKC levels were reduced in ZC-treated oocytes.
  • Evidence suggests a population of AURKA-CPC exists in mouse oocytes.

Conclusions:

  • INCENP-dependent activities of AURKA and AURKC are essential for maintaining spindle bipolarity and successful meiotic progression.
  • These findings highlight potential targets for understanding and preventing aneuploidy-related miscarriages.